Product
pNGVL4aCRTE6E7L2
2 clinical trials
6 indications
Indication
ASC-USIndication
Human Papillomavirus Type 16Indication
Cervical Intraepithelial NeoplasiaIndication
Grade IIIClinical trial
Phase I Clinical Trial Assessing the Safety and Feasibility of Intramuscular pNGVL4aCRTE6E7L2 and TA-CIN Administration for the Treatment of Patients With Persistent HPV16+ ASC-US or LSILStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Phase I Open Label, Dose Escalation Clinical Trial Assessing the Safety, Tolerability, and Feasibility of pNGVL4aCRTE6E7L2 HPV DNA Vaccine Administration Via Intramuscular TriGridTM Electroporation Delivery System to Patients With HPV16-Positive High-Grade Cervical Intraepithelial NeoplasiaStatus: Recruiting, Estimated PCD: 2024-09-30